Whatsapp Whatsapp
Telefon Hemen Ara

YAYINLAR

ULUSLARARASI YAYINLAR

Dergi Makaleleri

Durmus H, Shen XM, Serdaroglu-Oflazer P, Kara B, Parman-Gulsen Y, Ozdemir C, Brengman J, Deymeer F, Engel AG. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up. Neuromuscul Disord. 2018 Apr;28(4):315-322.

Shen XM, Brengman JM, Shen S, Durmus H, Preethish-Kumar V, Yuceyar N, Vengalil S, Nalini A, Deymeer F, Sine SM, Engel AG. Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit. JCI Insight. 2018 Jan 25;3(2).

Orhan EK, Kiraç LB, DİKmen PY, Matur Z, Ertaş M, Öge AE, Deymeer F, Yazici J, Baslo MB. Electromyography in Pediatric Population. Noro Psikiyatr Ars. 2018 Mar 19;55(1):36-39.

Sirin NG, Kocasoy Orhan E, Durmus H, Deymeer F, Baslo MB. Repetitive nerve stimulation and jitter measurement with disposable concentric needle electrode in newly diagnosed myasthenia gravis patients. Neurophysiol Clin. 2018 Feb 25. pii: S0987-7053(17)30270-8.

Güngor-Tuncer O, Yilmaz V, Toker A, Saruhan-Direskeneli G, Gulsen-Parman Y, Oflazer-Serdaroglu P, Deymeer F. Prompt Response to Prednisone Predicts Benign Course in MuSK-MG. Eur Neurol. 2017;78(3-4):137-142.

Durmus H, Yilmaz R, Gulsen-Parman Y, Oflazer-Serdaroglu P, Cuttini M, Dursun M, Deymeer F.

Muscle magnetic resonance imaging in spinal muscular atrophy type 3: Selective and progressive involvement. Muscle Nerve. 2017 May;55(5):651-656.

Alahgholi-Hajibehzad M, Durmuş H, Aysal F, Gülşen-Parman Y, Oflazer P, Deymeer F, Saruhan-Direskeneli G. The effect of interleukin (IL)-21 and CD4+ CD25++ T cells on cytokine production of CD4+ responder T cells in patients with myasthenia gravis. Clin Exp Immunol. 2017 Nov;190(2):201-207.

Inal-Gültekin G, Toptaş-Hekimoğlu B, Görmez Z, Gelişin Ö, Durmuş H, Ergüner B, Demirci H, Sağıroğlu MŞ, Parman Y, Deymeer F, Yılmaz-Aydoğan H, Pençe S, Bekircan-Kurt CE, Tan E, Erdem-Özdamar S, Üstek D, Giger U, Öztürk O, Serdaroğlu-Oflazer P. Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease. Neuromuscul Disord. 2017 Nov;27(11):997-1008.

Gökyigit MC, Ekmekci H, Durmus H, Karlı N, Koseoglu E, Aysal F, Kotan D, Ali A, Koytak PK, Karasoy H, Yaman A, Sengun İS, Sayin R, Tiftikcioglu BI, Soysal A, Tutkavul K, Bayrak AO, Kısabay A, Elci MA, Yayla V, Yılmaz İA, Ozdamar SE, Erdogan C, Tasdemir N, Serdaroglu Oflazer P; Turkish Study Group for Late Onset Pompe Disease. A database for screening and registering late onset Pompe disease in Turkey. Neuromuscul Disord. 2018 Mar;28(3):262-267.

İnal HS, Tarakçı E, Tarakçı D, Aksoy G, Mergen Kılıç S, Beşer H, Beşer Ç, Özdinçler AR, Durmuş Tekçe H, Parman FY, Deymeer F, Oflazer ZP. Turkish version of the Motor Function Measure Scale (MFM-32) forneuromuscular diseases: a cross-cultural adaptation, reliability, and validity study. Turk J Med Sci. 2017 Dec 19;47(6):1826-1833.

Durmuş H, Ayhan Ö, Çırak S, Deymeer F, Parman Y, Franke A, Eiber N, Chevessier F, Schlötzer-Schrehardt U, Clemen CS, Hashemolhosseini S, Schröder R, Hemmrich-Stanisak G, Tolun A, Serdaroğlu-Oflazer P. Neuromuscular endplate pathology in recessive desminopathies: Lessons from man and mice. Neurology. 2016 Aug 23;87(8):799-805.

Durmuş-Tekçe H, Matur Z, Mert Atmaca M, Poda M, Çakar A, Hıdır Ulaş Ü, Oflazer-Serdaroğlu P, Deymeer F, Parman YG. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Neuromuscul Disord. 2016 Jul;26(7):441-6.

Saruhan-Direskeneli G, Hughes T, Yilmaz V, Durmus H, Adler A, Alahgholi-Hajibehzad M, Aysal F, Yentür SP, Akalin MA, Dogan O, Marx A, Gülsen-Parman Y, Oflazer P, Deymeer F, Sawalha AH. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clin Immunol. 2016 May;166-167:81-8.

Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Gilhus NE, Casasnovas Pons C, Pitha J, Jakubíkova M, Hanisch F, Bogomolovas J, Labeit D, Labeit S, Tzartos SJ. Titin antibodies in “seronegative” myasthenia gravis–A new role for an old antigen. J Neuroimmunol. 2016 Mar 15;292:108-15.

Tsonis AI, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Casasnovas Pons C, Pitha J, Jakubíkova M, Hanisch F, Tzartos SJ. MuSK autoantibodies in myasthenia gravis detected by cell based assay–A multinational study. J Neuroimmunol. 2015 Jul 15;284:10-7.

Yılmaz V, Oflazer P, Aysal F, Durmus H, Poulas K, Yentur SP, Gulsen-Parman Y, Tzartos S, Marx A, Tuzun E, Deymeer F, Saruhan-Direskeneli G. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. PLoS One. 2015 Apr 20;10(4):e0123546.

Alahgholi-Hajibehzad M, Oflazer P, Aysal F, Durmuş H, Gülşen-Parman Y, Marx A, Deymeer F, Saruhan-Direskeneli G. Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity. J Neuroimmunol. 2015 Apr 15;281:51-60.

Yılmaz V, Oflazer P, Aysal F, Parman YG, Direskeneli H, Deymeer F, Saruhan-Direskeneli G. B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis. Autoimmunity 2015;48(4):201-7.

Özoğuz A, Uyan Ö, Birdal G, Iskender C, Kartal E, Lahut S, Ömür Ö, Agim ZS, Eken AG, Sen NE, Kavak P, Saygı C, Sapp PC, Keagle P, Parman Y, Tan E, Koç F, Deymeer F, Oflazer P, Hanağası H, Gürvit H, Bilgiç B, Durmuş H, Ertaş M, Kotan D, Akalın MA, Güllüoğlu H, Zarifoğlu M, Aysal F, Döşoğlu N, Bilguvar K, Günel M, Keskin Ö, Akgün T, Özçelik H, Landers JE, Brown RH, Başak AN. The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol Aging. 2015 Apr;36(4):1764.

Kaya GA, Coşkun AN, Yılmaz V, Oflazer P, Gülsen-Parman Y, Aysal F, Disci R, Direskeneli H, Marx A, Deymeer F, Saruhan-Direskeneli G. The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey. PLOS One 2014;9(8):e104760.

Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, Debaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun. 2014;52:139-45.

Güngor-Tuncer O, Orhan EK, Yilmaz V, Parman Y, Oflazer P, Saruhan-Direskeneli G, Deymeer F. Prepubertal anti-Musk positive myasthenia gravis with long remission. Neuromuscul Disord. 2014;24(1):36-9.

Alahgholi-Hajibehzad M, Yilmaz V, Gülsen-Parman Y, Aysal F, Oflazer P, Deymeer F, Saruhan-Direskeneli G. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey. Hum Immunol 2013;74(12):1633-5.

Uyan Ö, Ömür Ö, Ağım ZS, Özoğuz A, Li H, Parman Y, Deymeer F, Oflazer P, Koç F, Tan E, Özçelik H, Başak AN. Genome-wide copy number variation in sporadic amyotrophic lateral sclerosis in the Turkish population: deletion of EPHA3 is a possible protective factor. PLOS One 2013;26;8(8):e72381.

Selcen D, Shen XM, Milone MM, Brengman JM, Ohno K, Deymeer F, Finkel R, Rowin J, Engel AG. GFPT1-Myasthenia: Clinical, Structural, and Electrophysiologic Heterogeneity. Neurology 2013;81(4):370-8.

Orhan EK, Deymeer F, Oflazer P, Parman Y, Baslo MB. Jitter analysis with concentric needle electrode in the masseter muscle for the diagnosis of generalised myasthenia gravis. Clin Neurophysiol. 2013;124(11):2277-82.

Lahut S, Ömür Ö, Uyan Ö, Ağım ZS, Özoğuz A, Parman Y, Deymeer F, Oflazer P, Koç F, Özçelik H, Auburger G, Başak AN. ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLOS One 2012;7(8):e42956.

Ekizoğlu E, Yılmaz V, Içöz S, Birişik Ö, Tüzün E, Akman-Demir G, Saruhan-Direskeneli G, Deymeer F. Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma. Muscle Nerve 2013;47(2):306-7.

Shugaiv E, Kiyat-Atamer A, Tüzün E, Deymeer F, Oflazer P, Parman Y, Akman-Demir G. Coexistence of Guillain-Barré syndrome and Behçet’s disease. Clin Exp Rheumatol 2013;31(3 Suppl 77):88-9.

Oflazer PS, Deymeer F, Parman Y. Sporadic-inclusion body myositis (s-IBM) is not so prevalent in Istanbul/Turkey: a muscle based survey. Acta Myol 2011;30(1):34-6.

Tüzün E, Yılmaz V, Parman Y, Oflazer P, Deymeer F, Saruhan-Direskeneli G. Increased complement consumption in MuSK-antibody positive myasthenia gravis patients. Med Princ Pract 2011;20(6):581-583.

Deymeer F, Matur Z, Poyraz M, Battaloğlu E, Oflazer-Serdaroğlu P, Parman Y. Nerve conduction studies in Charcot-Marie-Tooth disease in a cohort from Turkey. Muscle Nerve 2011;43(5):657-64.

Durmuş H, Laval SH, Deymeer F, Parman Y, Kıyan E, Gökyigit, M, Ertekin C, Ercan I, Solakoglu S, Karcagi V, Straub V, Bushby K, Lochmüller H, Serdaroglu-Oflazer P.  Oculopharyngodistal myopathy is a distinct entity: Clinical and genetic features of 47 patients. Neurology 2011;76(3):227-35.

Kıyan E, Okumuş G, Çuhadaroğlu C, Deymeer F. Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 2010;14(1):19-24.

Toker A, Tanju S, Ziyade S, Özkan B, Sungur Z, Parman Y, Serdaroğlu P, Deymeer F. Early outcomes of video-assisted thoracoscopic resection of thymus in 181 patients with myasthenia gravis: who are the candidates for the next morning discharge? Interact Cardiovasc Thorac Surg 2009;9(6):995-8.

Li J, Qi H, Tüzün E, Allman W, Yılmaz V, Saini SS, Deymeer F, Saruhan-Direskeneli G, Christadoss P. Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis. J Neuroimmunol 2009;208(1-2):40-45.

Toker A, Tanju S, Sungur Z, Parman Y, Şentürk M, Serdaroğlu P, Dilege S, Deymeer F. Videothoracoscopic thymectomy for nonthymomatous myasthenia gravis: results of 90 patients. Surg Endosc 2008;22(4):912-6.

Yayla V, Öge AE, Deymeer F, Gurvit H, Akça-Kalem S, Parman Y, Oflazer P. Cortical excitability in Duchenne muscular dystrophy. Clin Neurophysiol 2008;119(2):459-65.

Deymeer F, Serdaroğlu P, Parman Y, Poda P. Natural history of SMA IIIb: Muscle strength decreases in a predictable sequence and magnitude. Neurology 2008;71(9):644-9.

Parman Y, Çiftçi F, Poyraz M, Halefoğlu AM, Öge AE, Eraksoy M, Saruhan-Direskeneli G, Deymeer F, Battaloğlu E. X-linked Charcot-Marie-Tooth disease and multiple sclerosis. J Neurol  2007;254(7):953-5.

Yılmaz V, Tütüncü Y, Barış Hasbel N, Parman Y, Serdaroğlu P, Deymeer F, Saruhan- Direskeneli G. Polymorphisms of interferon-gamma, interleukin-10, and interleukin-12 genes in myasthenia gravis. Hum Immunol 2007;68(6):544-9.

Deymeer F, Tuncer O, Yılmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G. Clinical comparison of anti-MuSK vs anti-AChR positive and seronegative myasthenia gravis. Neurology 2007;68:609-11.

Baslo BB, Deymeer F, Serdaroğlu P, Parman Y, Özdemir C, Cuttini M. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis. Neuromuscul Disord 2006;16: 454-8.

Shen XM, Deymeer F, Sine SM, Engel AG Slow-channel mutation in acetylcholine receptor alphaM4 domain and its efficient knockdown. Ann Neurol 2006;60(1):128-36.

Saruhan-Direskeneli G, Kiliç A, Parman Y, Serdaroğlu P, Deymeer F. HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum Immunol. 2006 Apr-May;67(4-5):352-8.

Deymeer F, Akça S, Kocaman G, Parman Y, Serdaroğlu P, Öktem-Tanör Ö, Çoban O, Vincent A. Fasciculations, autonomic symptoms and limbic encephalitis: a thymoma-associated Morvan’s-like syndrome. Eur Neurol 2005;54(4):235-7.

Parman Y, Battaloğlu E, Barış I, Bilir B, Poyraz M, Bissar-Tadmouri N, Williams A, Ammar N, Nelis E, Timmerman V, De Jonghe P, Necefov A, Deymeer F, Serdaroğlu P, Brophy PJ, Said G. Clinicopathological and genetic study of early-onset demyelinating neuropathy. Brain 2004;127:2540-50.

Bissar-Tadmouri N, Nelis E, Zuchner S, Parman Y, Deymeer F, Serdaroğlu P, De Jonghe P, Van Gerwen V, Timmerman V, Schroder JM, Battaloglu E. Absence of KIF1B mutation in a large Turkish CMT2A family suggests involvement of a second gene. Neurology 2004;62(9):1522-5.

Öztürk A, Deymeer F, Serdaroğlu P, Parman Y, Özdemir C. Distribution of extremity muscle weakness in myasthenia gravis: sparing of tibialis anterior muscle. Acta Myol 2003;22(2):58-60.

Akbaş F, Serdaroğlu P, Deymeer F, Aysal F, Erginel-Ünaltuna N. Molecular and clinical study of two myotonic dystrophy homozygotes. J Med Genet 2001;38(11):E40.

Plante-Bordeneuve V, Parman Y, Guiochon-Mantel A, Alj Y, Deymeer F, Serdaroğlu P, Eraksoy M, Said G. The range of chronic demyelinating neuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases. J Neurol 2001;248(9):795-803.

Christodoulou K, Deymeer F, Serdaroğlu P, Ozdemir C, Poda M, Georgiou DM, Ioannou P, Tsingis M, Zamba E, Middleton LT. Mapping of the second Friedreich’s ataxia (FRDA2) locus to chromosome 9p23-p11: evidence for further locus heterogeneity. Neurogenetics 2001; 3(3):127-32.

Önengüt S, Kavaslar GN, Battaloglu E, Serdaroglu P, Deymeer F, Ozdemir C, Calafell F, Tolun A. Deletion pattern in the dystrophin gene in Turks and a comparison with Europeans and Indians. Ann Hum Genet 2000;64:33-40.

Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, Geoerge AL Jr, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroğlu P, Subramony SH, Wolfe G, Fu YH, Ptacek LJ. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome. Cell 2001;18;105(4):511-519.

Bissar-Tadmouri N, Parman Y, Boutrand L, Deymeer F, Serdaroğlu P, Vandenberghe A, Battaloglu E. Mutational analysis and genotype/phenotype correlation in Turkish Charcot-Marie-Tooth Type 1 and HNPP patients. Clin Genet 2000;58(5):396-402.

Bissar-Tadmouri N, Gulsen-Parman Y, Latour P, Deymeer F, Serdaroğlu P, Vandenberghe A, Battaloğlu E. Two novel mutations in the MPZ gene coding region in Charcot-Marie-Tooth type 1 patients of Turkish origin:S54P, [I30del; GVYI29ins]. Hum Mutat (online) 1999;14:449.

Middleton L, Ohno K, Christodoulou K, Brengman J, Milone M, Neocleous V, Serdaroğlu P, Deymeer F, Özdemir C, Mubaidin A, Horany K, Al-Shehab A, Mavromatis I, Mylonas I, Tsingis M, Zamba E, Pantzaris M, Kyriallis K, Engel AG. Chromosome 17p linked myasthenias stem from defects in the acetylcholine recetor e subunit gene. Neurology 1999;53:1076-1082.

Deymeer F, Serdaroğlu P, Özdemir C. Familial infantile myasthenia: Confusion in terminology. Neuromuscul Disord 1999;9(3):129-130.

Deymeer F, Lehmann-Horn F, Serdaroğlu P, Çakırkaya S, Benz S, Rüdel R, Özdemir C. Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve 1999;22(1):123-125.

Deymeer F, Çakırkaya S, Serdaroğlu P, Schleithoff L, Lehmann-Horn F, Rüdel R. Özdemir C. Transient weakness and compound muscle action potential decrement in myotonia congenita. Muscle Nerve 1998;21(10):1334-1337.

Fleischhauer R, Mitrovic N, Deymeer F, Lehmann-Horn F, Lerche H. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita. Pflugers Arch 1998;436 (5):757-765.

Wagner S, Deymeer F, Kurz LL, Benz S, Ashleithoff L. Lehmann-Horn F, Serdaroğlu P, Özdemir C, Rüdel R. The dominant chloride channel mutant G200R causing fluctuating myotonia: clinical findings, electrophysiology, and channel pathology. Muscle Nerve 1998;21(9):1122-1128.

Deymeer F, Öge AE, Serdaroğlu P, Yazıcı J, Özdemir C, Baslo A. The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve 1998;21(5):643-646.

Deymeer F, Serdaroğlu P, Poda M, Gülşen-Parman Y, Özçelik T, Özdemir C. Segmental distribution of muscle weakness in SMA lll: Implications for deterioration in muscle strength with time. Neuromuscul Disord 1997;7(8):521-528.

Mailänder V, Heine R, Deymeer F, Lehmann-Horn F. Novel muscle chloride mutations and their effects on heterozygous carriers. Amer J Hum Genet 1996;58:317-324.

Kavaslar GN, Telatar M, Serdaroğlu P, Deymeer F, Özdemir C, Tolun A. Identification of a one base pair deletion in exon 6 of the dystrophin gene. Hum Mut 1995;6:85-86.

Deymeer F, Jones HR. Pediatric median mononeuropathies. Muscle Nerve 1994;17:755-762.

Heine R, George AL, Pika U, Deymeer F, Rüdel R, Lehmann-Horn F. Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a four base-pair deletion. Hum Mol Genet 1994;3:1123-1128.

Yates JRW, Warner JP, Smith UA, Deymeer F, Azulay JP, Hausmanowa-Petrusewicz I, Zaremba J, Borkowska J, Affara NA, Ferguson-Smith MA. Emery-Dreifuss muscular dystrophy: linkage to markers in distal Xq 28. J Med Genet 1993;30:108-111.

Deymeer F, Öge AE, Bayındır Ç, Kaymaz C, Niţancı Y, Adalet K, Yates JRW, Özdemir C. Emery-Dreifuss muscular dystrophy with unusual features. Muscle Nerve 1993;16:1359-1365.

Battaloğlu E, Telatar M, Deymeer F, Serdaroğlu P, Kuseyri F, Özdemir C, Apak M, Tolun A. DNA analysis in Turkish  Duchenne/Becker muscular dystrophy families. Hum Genet 1992;89:635-639.

Battaloglu E, Telatar M, Deymeer F, Serdaroğlu P, Özdemir C, Kuseyri F, Yüksel-Apak M, Apak S, Tolun A. Carrier detection by DNA analysis in Turkish Duchenne muscular dystrophy families. The Turkish J Pediatrics 1992;34:79-92.

Deymeer F, Smith TW, De Girolami U, Drachman DA. Thalamic dementia and motor neuron disease. Neurology 1989;39:58-61.

Deymeer F, Leviton A. Post-traumatic seizures: an assessment of the epidemiologic literature. Central Nervous System Trauma 1985;2(1):33-42.

Deymeer F, Leviton A. Perinatal factors and seizure disorders: an epidemiologic review. Epilepsia 1985;26(4):287-298.

Kulla L, Deymeer F, Smith TW, Weiner M, Mullins TF. Intracranial dissecting and saccular aneurysms in polycystic kidney disease. Archives of Neurology 1982;39(12):776-778.

 

Kitap Bölümleri ve Editörlük

Durmuş H, Serdaroglu-Oflazer P, Deymeer F: Emery-Dreifuss Muscular Dystrophy. Nuclear Envelopathies. In HR Jones, BT Darras, DC De Vivo (eds): Neuromuscular Diseases of Infancy, Childhood, and Adolescence: A Clinician’s Approach. Academic Press, 2015:667-678.

Deymeer F: Congenital Myasthenic Syndromes. In HR Jones, TM Burns, MJ Aminoff, Pomeroy SL (eds): The Netter Collection of Medical Illustrations. Nervous System. Part II Spinal Cord and Peripheral Motor and Sensory Systems. Elsevier,2013:253.

Deymeer F: Emery-Dreifuss Muscular Dystrophy. In HR Jones, BT Darras, DC De Vivo (eds): Neuromuscular Diseases of Infancy, Childhood, and Adolescence: A Clinician’s Approach. Butterworth-Heinemann,2002:753-763.

Deymeer F, Serdaroğlu P, Özdemir C: Juvenile and late-onset myasthenia gravis. In F Deymeer (ed): Neuromuscular Diseases: From Basic Mechanisms to Clinical Management. Basel, Karger,2000:113-127.

Deymeer F (ed). Neuromuscular Diseases: From Basic Mechanisms to Clinical Management. Basel, Karger,2000.

 

ULUSAL YAYINLAR

Dergi makaleleri

Durmuş Tekçe H, Deymeer F. Konjenital miyastenik sendromlar. Türkiye Klinikleri 2019 (baskıda)

Kocasoy-Orhan E, Baysal-Kıraç L, Yalınay-Dikmen P, Matur Z, Ertaş M, Öge AE, Deymeer F, Yazıcı J, Baslo MB. Pediatrik populasyonda elektromiyografi: İstanbul Tıp Fakültesi deneyimleri. Nöropsikiyatri Arşivi 2018;55: 36-39.

Gür S, Deymeer F, Oflazer P, Gülşen Parman Y. Poems Sendromu ve Multisentrik Castleman Hastalığında Ağrılı Polinöropati: Olgu Sunumu. Nöropsikiyatri Arşivi 2011; 48: 211-214.

Deymeer F. Konjenital miyastenik sendromlar. Türkiye Klinikleri 2011;4(2):110-6.

Deymeer F. Myasthenia Gravis’te Tanı ve Tedavi. Türkiye Klinikleri 2010;3(2):37-44.

Deymeer F. Nöromüsküler hastalıklarda elektromiyografi. Doktor 2006;33:48-50.

Deymeer F. Myasthenia Gravis’te kriz. Türkiye Klinikleri J Int Med Sci 2006;2(22):92-96.

Deymeer F. Myasthenia Gravis’te tedavi. Türkiye Klinikleri 2005;(1)22:38-43.

Deymeer F. Miyotonik sendromlar. Klinik Gelişim 1995;8:3733-3737.

Aysal F, Deymeer F, Serdaroğlu P, Öge AE, Çakır N, Tütüncü A, Özdemir C. Botulizm: Dört olgu nedeniyle klinik ve elektrofizyolojisi. Klinik Gelişim 1995;8:3761-3765.

Deymeer F, Özdemir C, Serdaroğlu P, Erseven G, Onursal E, Barlas C. Myasthenia Gravis’te timektomi sonuçları (94 olguluk inceleme). Nöro-Psikiatri Arşivi 1988;25(3-4):81-90.

 

Kitap Bölümleri

Saruhan-Direskeneli G, Deymeer F. Otoimmun Nöromüsküler Kavşak Hastalıkları. Rana Karabudak (ed): Temel ve Klinik Nöroimmunoloji. Ada Basın Yayın, 2013: 545-568.

Deymeer F. Nöromüsküler Kavşak Hastalıkları. Murat Emre (ed).: Nöroloji Temel Kitabı. Güneş Tıp Kitabevleri, 2013: 426-439.

Deymeer F. İskelet Kası İyon Kanallarının Herediter Hastalıkları. Murat Emre (ed): Nöroloji Temel Kitabı. Güneş Tıp Kitabevleri, 2013: 423-426.

Serdaroğlu, P, Deymeer F. Kas ve Nöromüsküler Kavşak Hastalıkları. A. Emre Öge (ed), Nöroloji Ders Kitabı (İ.Ü. İstanbul Tıp Fakültesi  Temel ve Klinik Bilimler Ders Kitapları).

Nobel Tıp Kitapevleri, 2011.

Deymeer F: Oküler Myasthenia Gravis. P Aydın, T Kansu, N Torun (eds): Nöro-Oftalmoloji El Kitabı. Güneş Tıp Kitabevi,2007:193-204.